0001181431-12-047611.txt : 20120827 0001181431-12-047611.hdr.sgml : 20120827 20120827213144 ACCESSION NUMBER: 0001181431-12-047611 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120823 FILED AS OF DATE: 20120827 DATE AS OF CHANGE: 20120827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEHRENS M KATHLEEN CENTRAL INDEX KEY: 0001211701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 121058244 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY STREET 2: SUITE 101 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 425-354-5038 MAIL ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY STREET 2: SUITE 101 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 rrd354452.xml X0306 4 2012-08-23 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001211701 BEHRENS M KATHLEEN 3450 MONTE VILLA PARKWAY, SUITE 101 BOTHELL WA 98021 1 0 0 0 Common Stock 2012-08-23 4 A 0 833 0 A 19166 D Stock Option (Right to Buy) 10.08 2012-08-23 4 A 0 5000 0 A 2022-08-23 Common Stock 5000 5000 D Grant of restricted stock, which shall vest in full on the earlier of (i) the anniversary date of the grant and (ii) the date of the 2013 annual meeting of shareholders. The number of shares reported reflects the 1-for-6 reverse stock split of the common stock of the Issuer effective as of July 11, 2012. Option shall vest in full on the earlier of (i) the anniversary date of the grant and (ii) the date of the 2013 annual meeting of shareholders. /s/ M. Kathleen Behrens 2012-08-27